中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/22436
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1498162      Online Users : 173
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > College of Medicine > School of Medicine > Proceedings >  Item 310903500/22436
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/22436


    Title: Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Authors: 魏鷰驕;吳世祿(Shih-Lu Wu);鄭欣怡;黃珊萍;程雲詳;蕭暖螢;侯庭鏞(Tin-Yun Ho);項千芸(Chien-Yun Hsiang)*
    Contributors: 醫學院醫學系學士班微生物學科
    Date: 2004-04-10
    Issue Date: 2009-09-07 11:59:56 (UTC+8)
    Abstract: Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a novel coronavirus and causing worldwide outbreaks. SARS coronavirus (SARS-CoV) is an enveloped RNA virus, which contains several structural proteins. Among these proteins, spike (S) protein is responsible for binding to specific cellular receptors and is a major antigenic determinant, which induces neutralizing antibody. In order to analyze the antigenicity and receptor-binding ability of SARS-CoV S protein, we expressed the S protein in Escherichia coli using a pET expression vector. After the isopropyl-β-D-thiogalactoside induction, S protein was expressed in the soluble form and was purified by nickel-affinity chromatography to homogeneity. The amount of S protein recovered was 0.2 to 0.3 mg per 100 ml bacterial culture. The S protein was recognized by sera from SARS patients by ELISA and Western blot, indicated that recombinant S protein remained its antigenicity. By biotinylated ELISA and Western blot using biotin-labeled S protein as the probe, we identified 130-kDa and 140-kDa proteins in Vero cells might be the cellular receptors responsible for SARS-CoV infection. Therefore, these results suggested that recombinant S protein exhibited the antigenicity and receptor-binding ability, and it could be a good candidate for further developing SARS vaccine and anti-SARS therapy.?
    Relation: The Nineteenth Joint Annual Conference of Biomedical Sciences
    Appears in Collections:[School of Medicine] Proceedings

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback